Enoticumab
Sign in to saveEnoticumab (REGN421, INN) is a human monoclonal antibody that binds to DLL4. It acts as an immunomodulator.
In the Vinony graph
Vinony's link graph records 260 inbound references to Enoticumab, and connects out to fusion protein, human and World Health Organization.
Vinony files it under Chemical pages without DrugBank identifier, Chemicals that do not have a ChemSpider ID assigned and Drugs not assigned an ATC code.
Vinony links it to 5 Wikipedia language editions.
Chemical data
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Antibody
- Indications
- cancer
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
Show 1 more fact
- subject has role
- monoclonal antibody
via Wikidata · CC0
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Enoticumab (REGN421, INN) is a human monoclonal antibody that binds to DLL4. It acts as an immunomodulator.
== References ==
Excerpted from Wikipedia’s “Enoticumab” article, available under the CC BY-SA 4.0 licence.
Connections
fusion protein
Entity
human
Entity
World Health Organization
Entity
bone
Entity
circulatory system
Entity
digital object identifier
Entity
neurology
Entity
antibody
Entity
PubMed
Entity
antigen
Entity
bibcode
Entity
CAS Registry Number
Entity
PubMed Central
Entity
neoplasm
Entity
Anatomical Therapeutic Chemical Classification System
Entity
human musculoskeletal system
Entity
World Health Organization Model List of Essential Medicines
Entity
clinical trial
Entity
monoclonal antibody
Entity
ChemSpider
Entity